title: Umeclidinium (Incruse Ellipta) for COPD.
authors.affiliation: Thundermist Health Center, Woonsocket, RI, USA.
authors.forename: R Christopher
authors.initials: RC
authors.lastname: Durigan
authors.affiliation: University of Pittsburgh Medical Center St. Margaret, Pittsburgh, PA, USA.
authors.forename: Valerie
authors.initials: V
authors.lastname: Niedermier
mesh_terms: D000280:Administration, Inhalation; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011812:Quinuclidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001993:Bronchodilator Agents; D018680:Cholinergic Antagonists; C573971:GSK573719; D011812:Quinuclidines